KMI
77
4
HAS
43
2
VNO
50
9
OI
43
4
XRAY
17
4
HPE
19
3
LB
64
9
DNB
60
2
GOOG
55
2
A
44
3
ADT
50
5
DAL
28
6
TDC
34
3
TGT
42
2
STI
20
2
UAL
51
6
ZBH
65
3
FE
64
4
CRM
39
5
NWSA
71
2
KMI
77
4
HAS
43
2
VNO
50
9
OI
43
4
XRAY
17
4
HPE
19
3
LB
64
9
DNB
60
2
GOOG
55
2
A
44
3
ADT
50
5
DAL
28
6
TDC
34
3
TGT
42
2
STI
20
2
UAL
51
6
ZBH
65
3
FE
64
4
CRM
39
5
NWSA
71
2
Financhill
Back

ACADIA Pharmaceuticals Stock Predictions

Your Data Made Them Billions-Now It's Your Turn to Profit

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55

ACAD
ACADIA Pharmaceuticals

Last Price:
$17.49
Seasonality Move:
19.92%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

ACADIA Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, ACADIA Pharmaceuticals has on average historically risen by 35.3% based on the past 20 years of stock performance.
  • ACADIA Pharmaceuticals has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
  • Is ACADIA Pharmaceuticals Stock Undervalued?
    The current ACADIA Pharmaceuticals [ACAD] share price is $17.50. The Score for ACAD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • ACAD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will ACADIA Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, ACADIA Pharmaceuticals has on average historically risen by 35.3% based on the past 20 years of stock performance.

ACADIA Pharmaceuticals Stock Rating

Buy
55
ACADIA Pharmaceuticals (ACAD) is a Buy

Is ACADIA Pharmaceuticals overpriced?

  • ACADIA Pharmaceuticals has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%

ACADIA Pharmaceuticals Stock Price History

Is ACAD stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
acadia.com

52-Week Data

52-Week High:
20.68
52-Week Low:
14.15

Prediction Charts

Market Cap:
2.9B
Price in USD:
17.50
Volume:
2M
Beta:
1.76

Technical Analysis

SMA50:
18.35
SMA100:
17.35
SMA200:
16.74
52-Wk Change:
-6.57%

Stock Predictions

  • Is ACADIA Pharmaceuticals stock public?
    Yes, ACADIA Pharmaceuticals is a publicly traded company.
  • What is the ACADIA Pharmaceuticals stock quote today?
    The ACADIA Pharmaceuticals stock price is 17.50 USD today.
  • How to buy ACADIA Pharmaceuticals stock online?
    You can buy ACADIA Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-21 20.51 19.94 20.68 19.92
Feb-25 19.52 19.01 19.72 18.90
Feb-26 19.08 19.00 19.65 18.93
Feb-27 19.44 19.33 20.62 18.83
Feb-28 19.04 19.58 19.62 19.00
Mar-3 19.56 18.16 19.69 18.10
Mar-4 18.16 18.26 18.54 17.85
Mar-5 18.37 18.08 18.52 18.02
Mar-6 17.85 17.60 18.15 17.59
Mar-7 17.62 17.56 17.86 17.33
Mar-11 17.10 17.19 17.45 16.86
Mar-12 17.23 16.77 17.40 16.75
Mar-13 16.67 16.78 16.91 16.59
Mar-14 16.91 17.50 17.70 16.71

ACADIA Pharmaceuticals Earnings

ACADIA Pharmaceuticals Earnings Report: Per Share ACADIA Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

ACADIA Pharmaceuticals Forecast Revenue Growth

ACADIA Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for ACADIA Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.43 per share.

* ACADIA Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.